Clinical and Economic Considerations for the Use of Erythropoiesis-Stimulating Agents
March 4th 2011
Erythropoiesis-stimulating agents (ESAs) are genetically engineered forms of erythropoietin that stimulate erythropoiesis through direct or indirect action on the erythropoietin receptor producing an increase